{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:24:18Z","timestamp":1792110258755,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ajo.2010.08.037","type":"journal-article","created":{"date-parts":[[2010,12,19]],"date-time":"2010-12-19T04:06:15Z","timestamp":1292731575000},"page":"353-357.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Vitreous Levels of Angiopoietin-1 and Angiopoietin-2 in Eyes With Retinopathy of Prematurity"],"prefix":"10.1016","volume":"151","author":[{"given":"Tatsuhiko","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2010.08.037_bib1","first-page":"262","article-title":"Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects","volume":"40","author":"Terry","year":"1942","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"4","key":"10.1016\/j.ajo.2010.08.037_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00129785-200303040-00004","article-title":"Retinopathy of prematurity: molecular pathology and therapeutic strategies","volume":"3","author":"Mechoulam","year":"2003","journal-title":"Am J Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.ajo.2010.08.037_bib3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2010.08.037_bib4","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","article-title":"Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2010.08.037_bib5","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.ophtha.2009.04.026","article-title":"Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2010.08.037_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.ajo.2010.08.037_bib7","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study","volume":"92","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.08.037_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emm.2002.1","article-title":"Biomedical significance of endothelial cell specific growth factor, angiopoietin","volume":"34","author":"Koh","year":"2002","journal-title":"Exp Mol Med"},{"issue":"5322","key":"10.1016\/j.ajo.2010.08.037_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ajo.2010.08.037_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/labinvest.3780433","article-title":"Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo","volume":"82","author":"Sundberg","year":"2002","journal-title":"Lab Invest"},{"issue":"6535","key":"10.1016\/j.ajo.2010.08.037_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/376070a0","article-title":"Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation","volume":"376","author":"Sato","year":"1995","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ajo.2010.08.037_bib12","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","article-title":"Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning","volume":"87","author":"Davis","year":"1996","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ajo.2010.08.037_bib13","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"issue":"38","key":"10.1016\/j.ajo.2010.08.037_bib14","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/sj.onc.1203035","article-title":"New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF","volume":"18","author":"Holash","year":"1999","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.ajo.2010.08.037_bib15","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1073\/pnas.1434429100","article-title":"Endothelial cell diversity revealed by global expression profiling","volume":"100","author":"Chi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ajo.2010.08.037_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1167\/iovs.02-0276","article-title":"Potential role of the angiopoietin\/tie2 system in ischemia-induced retinal neovascularization","volume":"44","author":"Takagi","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2010.08.037_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/01.RES.83.3.233","article-title":"Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulated VEGF-induced postnatal neovascularization","volume":"83","author":"Asahara","year":"1998","journal-title":"Circ Res"},{"issue":"22","key":"10.1016\/j.ajo.2010.08.037_bib18","doi-asserted-by":"crossref","first-page":"15732","DOI":"10.1074\/jbc.274.22.15732","article-title":"Hypoxia and vascular endothelial growth factor selectively up-regulated angiopoietin-2 in bovine microvascular endothelial cells","volume":"274","author":"Oh","year":"1999","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.ajo.2010.08.037_bib19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.RES.83.8.852","article-title":"Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia","volume":"83","author":"Mandriota","year":"1998","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.ajo.2010.08.037_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"International committee for the classification of retinopathy of prematurity","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2010.08.037_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0886-3350(13)80659-1","article-title":"Posterior capsulorhexis with optic capture: maintaining a clear visual axis after pediatric cataract surgery","volume":"20","author":"Gimbel","year":"1994","journal-title":"J Cataract Refract Surg"},{"issue":"5449","key":"10.1016\/j.ajo.2010.08.037_bib22","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1126\/science.286.5449.2511","article-title":"Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1","volume":"286","author":"Thurston","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ajo.2010.08.037_bib23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ajo.2010.08.037_bib24","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0002-9440(10)61115-7","article-title":"Suppression of diabetic retinopathy with angiopoietin-1","volume":"160","author":"Joussen","year":"2002","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.ajo.2010.08.037_bib25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/diabetes.53.4.1104","article-title":"Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy","volume":"53","author":"Hammes","year":"2004","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ajo.2010.08.037_bib26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ajo.2004.10.004","article-title":"Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy","volume":"139","author":"Watanabe","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.08.037_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bjo.2008.142646","article-title":"Comprehensive gene expression profile in murine oxygen-induced retinopathy","volume":"93","author":"Sato","year":"2009","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939410006719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939410006719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:03:20Z","timestamp":1757595800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939410006719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0002939410006719"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2010.08.037","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitreous Levels of Angiopoietin-1 and Angiopoietin-2 in Eyes With Retinopathy of Prematurity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2010.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}